RT Journal Article
SR Electronic
T1 Factors Associated with Coronavirus (COVID-19) Deaths and Infections: A Cross Country Evidence
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.02.20183236
DO 10.1101/2020.11.02.20183236
A1 Shafiun Nahin Shimul
A1 Fariha Kadir
A1 Muhammad Ihsan- Ul- Kabir
YR 2020
UL http://medrxiv.org/content/early/2020/11/04/2020.11.02.20183236.abstract
AB Though most of the countries across the world are crippled with COVID-19, there has been substantial variations in death and infection rates. While some countries are overwhelmed, a few are spared. Little is known what explains this variation. This study attempts to understand the covariates of death and infection rates of COVID-19 across countries using multivariate regression analysis and least absolute shrinkage and selection operator (LASSO) regression. The OLS estimates show that the aging population and hospital bed per capita are significantly associated with the fatality rate of COVID-19, while urbanization has a positive correlation with the inflection rate. The study suggests that an increase in health systems capacity can significantly reduce the fatality rates due to COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received for this studyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Secondary data is used so no IRB was required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe study uses publicly available data that has been cited with the proper links. However, authors are ready to share data if requested.